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1. Introduction 
Recent reports [ 1,2] indicated the presence of 
seven metabolites of prostaglandin Ez (PGE,) and 
five metabolites of prostaglandin Fzor (PGFZLY) in the 
urine of rats after intravenous injection with radioac- 
tive prostaglandins. These results suggested that PGE, 
and PGF2, are converted into three groups of metabo- 
lites via three separate pathways which involve oxida- 
tion of the hydroxyl group at C-15 [3], reduction of 
the tram double bond [3], B [4] and o oxidations. 
Previous studies from this laboratory have established 
the binding in vitro of PGEZ, PGF,, and prostaglandin 
AZ @‘GA,) to plasma albumin [5,6]. Studies with 
rats that received intravenous injections of prosta- 
glandin PGFZa and PGAz [7] showed this binding to 
significantly modify the in vivo metabolism of these 
prostaglandins as judged from the disappearance of 
the injected prostaglandins from the blood circulation 
and the appearance of their metabolites. This report 
describes differences in the in vivo metabolism of 
intravenously injected free and albumin-bound PGEz . 
2. Materials and methods 
Prostaglandins Ez, Fza, 15-keto E 1, A2 and 15-keto 
A, were kindly provided by Dr. John E. Pike (The 
Upjohn Co., Kalamazoo, Mich., USA). ‘H-labeled 
arachidonic acid, specific activity 1.22 Ci/mmole was 
obtained from New England Nuclear (Boston, Mass., 
USA) and used for the biosynthesis of 3 H-labeled PGE, 
using a purified enzyme preparation from sheep senimal 
vesicles prepared as described elsewhere [8]. 
Rats weighing approx. 100 g were divided into two 
groups of 4 rats each, anesthetised with ether and 
injected into the femoral vein with 0.2 ml of either 
PGEZ -saline solution (0.2 mg/ml) or PGEl -rat plasma 
solution (0.2 mglml). Each injected aliquot contained 
2 X 10’ cpm of 3H-labeled PGEz [5]. Blood (1.5- 
2.0 ml) was withdrawn by heart puncture into a 
heparinized syringe 30-45 set after injection. Plasma 
was immediately isolated, 50 yl aliquots taken for 
determination of total radioactivity and the remaining 
portion extracted for prostaglandins. A mixture of 
prostaglandins containing FZa, Ez , 15.keto El, AZ 
and 15-keto A, (20 pg each) was added to the extract 
and thin-layer chromatography performed using 
chloroform-tetrahydrofurane-acetic acid (10:2: 1) 
[9] as developing solvent. The above mentioned 
prostaglandins were run as reference compounds in 
each chromatographic separation. Plates were divided 
into zones according to the mobilities of these standards, 
each zone scraped into a scintillation vial and counted 
in Bray solution [lo]. The counts were corrected for 
quenching by adding tritiated toluene as an external 
standard. Further details on the preparation of the 
injected PGE,-containing solutions and on the method 
of prostaglandins extraction from plasma has been 
described previously [7]. 
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Fig. 1. Radioactivity distribution among prostaglandin metabo- 
lites following thin-layer chromatography of lipid extracts ob- 
tained from rat plasma after intravenous injection of either 
PGEa-saline solution (top figure) or PCEa-rat plasma solution 
(bottom figure). Values in parenthesis above bars represent % 
of total radioactivity in the indicated zones. 
3. Results and discussion 
The total radioactivity recovered in the blood (as- 
suming a total blood volume of 10 ml for the 100 g 
rat used) was found to be 16-20% in rats which receiv- 
ed PGEz -saline solution, and 24-28% in rats injected 
with PGEz-rat plasma solution. The distribution of 
the radioactivity among the various prostaglandin 
metabolites is shown in fig. 1. The data in each part 
of the figure was obtained from a plasma extract taken 
from a single rat. Similar results were obtained for the 
remaining three rats in each group, respectively. 
Significant differences were observed in the relative 
amounts of IS-keto PGEz and PGAz in the plasma of 
rats in the two groups. In the plasma of rats injected 
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with PGEz -saline solution, the major metabolite 
formed was 15keto PGEl (45.6%), while PGAg was 
only a minor component (11.4%). In contrast, with 
rats injected with PGEz -rat plasma solution (i.e. PGEz 
mostly bound to rat albumin) the major metabolite 
was PGAz (45.2%) while I.5keto PGEz was a minor 
component (12.2%). The possible chemical conversion 
of PGEz to PGAz during the extraction procedure was 
checked for by adding radioactive PGEz to rat plasma 
followed by extraction and thin-layer chromatography. 
Approx. 0.5-l% of the recovered radioactivity was 
associated with the PGAz zone, indicating negligible, 
conversion of PGEz to PGA? during the extraction. 
The conversion of PGE type prostaglandins in 
plasma to their 15.keto derivatives during passage 
through the lungs is considered to be a part of the 
normal metabolic fate of these protaglandins. An en- 
zyme carrying out this reaction (a prostaglandin 15. 
OH dehydrogenase) has been partially purified from 
guinea pig lungs [ 1 I]. The results described here 
indicate that the metabolic fate of intravenously in- 
jected PGE, depends on whether PGEz is injected in 
the free form, or bound to albumin. The binding of 
PGEz to rat albumin prior to its injection into the 
blood appears to reduce its availability for the 15.OH 
dehydrogenase nzyme, thereby decreasing the rate 
of formation of 15.keto PGE, . A reduced availability 
of PGEz as a result of albumin binding was also ob- 
served in previous studies from this laboratory [ 51 
which showed the binding of PGEz to human serum 
albumin to render PGE, inactive in producing con- 
tractions on isolated gerbil colon in vitro. Further 
studies are in progress in order to determine what, if 
any, are the metabolic relationships between the de- 
creased formation of 15.keto PGEz and the apparent 
concurrent increase in the amount of PGAz formed 
when PGEz is administered bound to plasma albumin. 
References 
[l] K. Green, Biochemistry 10 (1971) 1072. 
[Z] K. Green, Biochim. Biophys. Acta 231 (1971) 419. 
[3] E. Anggard, K. Green and B. Samuelsson, J. Biol. Chem. 
240 (1965) 1932. 
[4] M. Hamberg, European J. Biochem. 6 (1968) 135. 
[S] A. Raz, Biochim. Biophys. Acta, in press. 
[6] A. Raz, Biochem. J., in press. 
[ 7 ] A. Raz, Life Sciences, in press. 
Volume 27, number 2 FEBS LETTERS November 1972 
[ 81 D.P. Wallach and E.G. Daniels, Biochim. Biophys. Acta 
231 (1971) 445. 
[9] N.H. Anderson, J. Lipid Res. 10 (1969) 316. 
[lo] A.G. Bray, Anal. Biochem. 1 (1960) 279. 
[ll] A. Xnggard and B, Samuelsson, Arkiv Kemi 25 (1966) 
293. 
247 
